수술 및 시술 시 항혈전제 사용에 대한 전문가 합의문: 2부. 증례편

키워드

참고문헌 (61)

1. Fujimoto K, "Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment", Dig Endosc, 26, pp.1~14 (2014)
2. Gralnek IM, "Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage:European Society of Gastrointestinal Endoscopy (ESGE) Guideline", Endoscopy, 47, pp.a1~a46 (2015)[DOI]
3. ASGE Standards of Practice Committee, "The management of antithrombotic agents for patients undergoing GI endoscopy", Gastrointest Endosc, 83, pp.3~16 (2016)
4. Veitch AM, "Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines", Endoscopy, 48, pp.385~402 (2016)
5. Lee SY, "Managing anticoagulation and antiplatelet medications in GI endoscopy : a survey comparing the East and the West", Gastrointest Endosc, 67, pp.1076~1081 (2008)
6. Chan FKL, "Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines", Gut, 67, pp.405~417 (2018)
7. 김준성, "항혈전제 복용 환자에서 내시경", 대한소화기학회지, 71(5), pp.282~285 (2018), 대한소화기학회[DOI]
8. Valgimigli M, "2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS : The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology(ESC)and of the European Association for Cardio-Thoracic Surgery(EACTS)", Eur Heart J, 39, pp.213~260 (2018)
9. Douketis JD, "Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant", JAMA Intern Med, 179, pp.1469~1478 (2019)
10. 이지현, "2018 대한부정맥학회 심방세동 환자에서 NOAC 사용 지침: 출혈의 대처와 수술 전후 복약관리", 대한내과학회지, 94(1), pp.40~56 (2019), 대한내과학회[DOI]
11. Steffel J, "The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation", Eur Heart J, 39, pp.1330~1393 (2018)
12. Banerjee S, "Use of antiplatelet therapy", DAPT for post-PCI patients undergoing noncardiac surgery, 2017, pp.69, 1861~1870
13. Coccolini F, "Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis", Int J Surg, 18, pp.196~204 (2015)
14. Jackson PG, "Sabiston textbook of surgery", pp.1482~1519 (2016), Elsevier
15. Blumgart LH, "Blumgart's surgery of the liver, biliary tract and pancreas", pp.32~59 (2016), Elsevier
16. Doleman B, "Is early hip fracture surgery safe for patients on clopidogrel? Systematic review, meta-analysis and meta-regression", Injury, 46, pp.954~962 (2015)
17. Rossini R, "Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies", EuroIntervention, 10, pp.38~46 (2014)
18. Fleisher LA, "2014ACC", AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology, J Am Coll Cardiol, pp.2014, 64[DOI]
19. To AC, "Noncardiac surgery and bleeding after percutaneous coronary intervention", Circ Cardiovasc Interv, 2, pp.213~221 (2009)
20. Burger W, "Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis", J Intern Med, 257, pp.399~414 (2005)
21. Kang SB, "Does low-dose aspirin increase blood loss after spinal fusion surgery?", Spine J, 11, pp.303~307 (2011)
22. Park JH, "Antithrombotic effects of aspirin on 1- or 2-level lumbar spinal fusion surgery: a comparison between 2 groups discontinuing aspirin use before and after 7 days prior to surgery", Spine (Phila Pa 1976), 38, pp.1561~1565 (2013)
23. Park HJ, "Comparison of blood loss according to use of aspirin in lumbar fusion patients", Eur Spine J, 23, pp.1777~1782 (2014)
24. 양승민, "Spontaneous Spinal Epidural Hematomas Associated With Acute Myocardial Infarction Treatment", Korean Circulation Journal, 41(12), pp.759~762 (2011), 대한심장학회
25. Cuellar JM, "Does aspirin administration increase perioperative morbidity in patients with cardiac stents undergoing spinal surgery?", Spine (Phila Pa 1976), 40, pp.629~635 (2015)
26. Zhang C, "Safety of continuing aspirin therapy during spinal surgery: a systematic review and meta-analysis", Medicine (Baltimore), 96, pp.e8603~ (2017)
27. Hong SJ, "Effect of perioperative antiplatelet therapy on outcomes in patients with drug-eluting stents undergoing elective noncardiac surgery", Am J Cardiol, 123, pp.1414~1421 (2019)
28. Levine GN, "2016 ACC", AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology, AHA, pp.SCAI guideline for percutaneous coronary intervention, 2011 ACCF, AHA guideline for coronary artery bypass graft surgery, 2012ACC[DOI]
29. Rossini R, "A multidisciplinary approach on the perioperative antithrombotic management of patients with coronary stents undergoing surgery: surgery after stenting 2", JACC Cardiovasc Interv, 11, pp.417~434 (2018)
30. Graham MM, "Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery", Ann Intern Med, 168, pp.237~244 (2018)
31. Carmignani L, "Transrectal ultrasound-guided prostate biopsies in patients taking aspirin for cardiovascular disease: a meta-analysis", Transfus Apher Sci, 45, pp.275~280 (2011)
32. Mottet N, "EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent", Eur Urol, 71, pp.618~629 (2017)
33. Culkin DJ, "Anticoagulation and antiplatelet therapy in urological practice : ICUD", AUA review paper, 2014, pp.192, 1026~1034
34. Pigot F, "Do we have to stop anticoagulant and platelet-inhibitor treatments during proctological surgery?", Colorectal Dis, 14, pp.1516~1520 (2012)
35. 윤경철, "Prevalence of Eye Diseases in South Korea: Data from the Korea National Health and Nutrition Examination Survey 2008-2009", Korean Journal of Ophthalmology, 25(6), pp.421~433 (2011), 대한안과학회
36. Baron TH, "Management of antithrombotic therapy in patients undergoing invasive procedures", N Engl J Med, 368, pp.2113~2124 (2013)
37. Dézsi CA, "Management of dental patients receiving antiplatelet therapy or chronic oral anticoagulation : a review of the latest evidence", Eur J Gen Pract, 23, pp.196~201 (2017)
38. Abraham NS, "ACCF", ACG, ACG, pp.AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A report of the American College of Cardiology foundation task force on expert consensus documents, J Am Coll Cardiol[DOI]
39. Agewall S, "Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy", Eur Heart J, 34, pp.1708~1713b (2013)
40. O'Donoghue ML, "Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials", Lancet, 374, pp.989~997 (2009)
41. Bhatt DL, "Clopidogrel with or without omeprazole in coronary artery disease", N Engl J Med, 363, pp.1909~1917 (2010)
42. Gargiulo G, "Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6-or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial", Am Heart J, 174, pp.95~102 (2016)
43. Goodman SG, "Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial", Circulation, 125, pp.978~986 (2012)
44. Vranckx P, "Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial", Lancet, 392, pp.940~949 (2018)
45. Mehran R, "Ticagrelor with or without aspirin in high-risk patients after PCI", N Engl J Med, 381, pp.2032~2042 (2019)
46. Watanabe H, "Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2randomized clinical trial", JAMA, 321, pp.2414~2427 (2019)
47. Hahn JY, "Effect of p2y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention:the SMART-CHOICE randomized clinical trial", JAMA, 321, pp.2428~2437 (2019)
48. Cordonnier C, "Intracerebral haemorrhage : current approaches to acute management", Lancet, 392, pp.1257~1268 (2018)
49. Bailey RD, "Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage", Neurology, 56, pp.773~777 (2001)
50. Pennlert J, "Antithrombotic treatment following intracerebral hemorrhage in patients with and without atrial fibrillation", Stroke, 46, pp.2094~2099 (2015)
51. Chao TF, "Use of oral anticoagulants for stroke prevention in patients with atrial fibrillation who have a history of intracranial hemorrhage", Circulation, 133, pp.1540~1547 (2016)
52. Majeed A, "Optimal timing of resumption of warfarin after intracranial hemorrhage", Stroke, 41, pp.2860~2866 (2010)
53. Pennlert J, "Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation", Stroke, 48, pp.314~320 (2017)
54. López-López JA, "Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis", BMJ, 359, pp.j5058~ (2017)
55. Proietti M, "Real-world use of apixaban for stroke prevention in atrial fibrillation : a systematic review and meta-analysis", Stroke, 49, pp.98~106 (2018)
56. Haeusler KG, "Brain MRI to personalise atrial fibrillation therapy : current evidence and perspectives", Heart, 100, pp.1408~1413 (2014)
57. Kazui S, "Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course", Stroke, 27, pp.1783~1787 (1996)
58. Zazulia AR, "Progression of mass effect after intracerebral hemorrhage", Stroke, 30, pp.1167~1173 (1999)
59. Kamenova M, "does early resumption of low-dose aspirin after evacuation of chronic subdural hematoma with burr-hole drainage lead to higher recurrence rates?", Neurosurgery, 79, pp.715~721 (2016)
60. Hawryluk GW, "Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk", J Thromb Haemost, 8, pp.1500~1508 (2010)
61. Chatterjee S, "New oral anticoagulants and the risk of intracranial hemorrhage : traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation", JAMA Neurol, 70, pp.1486~1490 (2013)

관련 논문AI추천